Search - tctmd.com

Displaying 661 - 680 of 816

Sort: Relevancy | Date

News Conference News TCT 2013

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

October 28, 2013

News Industry News

Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure

October 28, 2013

News Daily News

System-Wide Effort Produces Lasting Improvement in D2B Times for STEMI Transfers

Caitlin E. Cox

September 27, 2013

News Daily News

Better Door-to-Balloon Times Do Not Translate to Lower Mortality in STEMI Patients

Jason Kahn

September 05, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

August 19, 2013

News Daily News

Quitting Smoking After PCI Can Add Years to Patients’ Lives

L.A. McKeown

August 05, 2013

News Industry News

PTS, Inc. Introduces CardioChek® Plus Analyzer

July 30, 2013

News Industry News

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

July 28, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Industry News

Boston Scientific Launches Guidezilla™ Guide Extension Catheter in U.S. and Europe

July 12, 2013

News Industry News

STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications

July 10, 2013

News Daily News

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

June 21, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

News Daily News

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

Caitlin E. Cox

June 03, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Industry News

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

May 22, 2013

News Industry News

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

May 22, 2013

News Industry News

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

May 21, 2013

Advertisement

Long-Term Outcomes, Cost May Influence Use of TAVR in Moderate-Risk Patients

Juventas Therapeutics completes enrollment of Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure

System-Wide Effort Produces Lasting Improvement in D2B Times for STEMI Transfers

Better Door-to-Balloon Times Do Not Translate to Lower Mortality in STEMI Patients

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

Quitting Smoking After PCI Can Add Years to Patients’ Lives

PTS, Inc. Introduces CardioChek® Plus Analyzer

Samsung Partnership with Scotland’s NHS Highlights Lifesaving Potential of Mobile Cardiac Diagnosis

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

Boston Scientific Launches Guidezilla™ Guide Extension Catheter in U.S. and Europe

STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications

Oral Anticoagulant Use for A-fib in Community Practice Appears Appropriate

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

Meta-analysis Confirms Connection Between High-Dose NSAIDs, Vascular Risk

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

New Data Demonstrate Significant And Sustained Blood Pressure Reduction With Boston Scientific Vessix™ Renal Denervation System

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data

Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content